- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging systemic drugs in the treatment of plaque psoriasis
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2020-03-20
DOI
10.1080/14728214.2020.1745773
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of mirikizumab ( LY 3074828) in the treatment of moderate‐to‐severe plaque psoriasis: results from a randomized phase II study
- (2019) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- The Therapeutic Potential of Nanobodies
- (2019) Ivana Jovčevska et al. BIODRUGS
- Psoriasis: A STAT3-Centric View
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
- (2018) Kim A. Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- GM-CSF as a therapeutic target in psoriasis: randomised, controlled investigation using namilumab - a specific, human anti-GM-CSF monoclonal antibody
- (2018) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Tofacitinib for the treatment of psoriasis and psoriatic arthritis
- (2018) Anna Berekmeri et al. Expert Review of Clinical Immunology
- Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
- (2018) Kim Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Small molecule therapy for managing moderate to severe psoriatic arthritis
- (2017) Luisa Costa et al. EXPERT OPINION ON PHARMACOTHERAPY
- Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment
- (2017) Stephen Hu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Psoriasis pathogenesis and the development of novel targeted immune therapies
- (2017) Jason E. Hawkes et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition
- (2017) Robert Bissonnette et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Psoriatic Disease 10 Years Later
- (2017) RAFFAELE SCARPA et al. JOURNAL OF RHEUMATOLOGY
- JAK inhibitors in dermatology: The promise of a new drug class
- (2017) William Damsky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Cognitive Impairment in Patients with Psoriasis: A Cross-Sectional Study Using the Montreal Cognitive Assessment
- (2016) Emine Colgecen et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Novel Oral Therapies for Psoriasis and Psoriatic Arthritis
- (2016) Zenas Z. N. Yiu et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Emerging drugs for psoriatic arthritis
- (2016) Francesco Caso et al. EXPERT OPINION ON EMERGING DRUGS
- Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathologyin vivo
- (2016) Daliya Banerjee et al. IMMUNOLOGY
- Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
- (2016) A. Menter et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Treatment of two patients with generalized pustular psoriasis with the interleukin-1β inhibitor gevokizumab
- (2015) B. Mansouri et al. BRITISH JOURNAL OF DERMATOLOGY
- Transcriptional network profile on synovial fluid T cells in psoriatic arthritis
- (2015) Ugo Fiocco et al. CLINICAL RHEUMATOLOGY
- New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors
- (2015) Anthony A. Gaspari et al. Dermatologic Therapy
- Emerging oral drugs for psoriasis
- (2015) Tahmina Mahmood et al. EXPERT OPINION ON EMERGING DRUGS
- The psoriasis drugs market
- (2015) Salman Rizvi et al. NATURE REVIEWS DRUG DISCOVERY
- Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)
- (2014) A.B. Kimball et al. BRITISH JOURNAL OF DERMATOLOGY
- JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis
- (2014) Ugo Fiocco et al. IMMUNOLOGIC RESEARCH
- Psoriasis
- (2014) P. Di Meglio et al. Cold Spring Harbor Perspectives in Medicine
- Janus kinase inhibitors in autoimmune diseases
- (2013) John J O'Shea et al. ANNALS OF THE RHEUMATIC DISEASES
- Current and Emerging Systemic Treatment Strategies for Psoriasis
- (2012) Philip M. Laws et al. DRUGS
- Biological therapy of psoriasis
- (2010) Emanual Maverakis et al. INDIAN JOURNAL OF DERMATOLOGY
- Emerging drugs for psoriasis
- (2009) Luigi Naldi et al. EXPERT OPINION ON EMERGING DRUGS
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
- (2007) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More